Atherosclerotic plaque formation is fueled by the persistence of lipid-laden macrophages in the artery wall. The mechanisms by which these cells become trapped, thereby establishing chronic inflammation, remain unknown. Here we found that netrin-1, a neuroimmune guidance cue, was secreted by macrophages in human and mouse atheroma, where it inactivated the migration of macrophages toward chemokines linked to their egress from plaques. Acting via its receptor, UNC5b, netrin-1 inhibited the migration of macrophages directed by the chemokines CCL2 and CCL19, activation of the actin-remodeling GTPase Rac1 and actin polymerization. Targeted deletion of netrin-1 in macrophages resulted in much less atherosclerosis in mice deficient in the receptor for low-density lipoprotein and promoted the emigration of macrophages from plaques. Thus, netrin-1 promoted atherosclerosis by retaining macrophages in the artery wall. Our results establish a causative role for negative regulators of leukocyte migration in chronic inflammation. npg
A R T I C L E S
Atherosclerosis is a disease of chronic inflammation that is distinguished by the persistence of cholesterol-engorged macrophages in arterial plaques. Arterial inflammation is initiated by the subendothelial retention of plasma low-density lipoproteins (LDLs) and is enhanced by oxidative modification of these lipoproteins, which triggers the influx of monocytes 1 . Unlike other inflammatory states, atherosclerotic inflammation does not readily resolve, and cholesterol-laden macrophages persist in the arterial wall. These macrophage ' foam cells ' cause expansion of the plaque though the recruitment of additional leukocytes and vascular smooth muscle cells (SMCs) and contribute prominently to plaque instability via the secretion of extracellular matrix -degrading proteases and cytotoxic factors. Notably, atherosclerotic plaques that cause clinical events (such as myocardial infarction and stroke) are characterized by abundant macrophage content 2 .
Although the retention of macrophages in the artery wall has long been recognized as a fundamental step in the creation of the chronic inflammatory milieu that underlies atherosclerosis, the mechanisms that regulate this process are not well understood. The resolution of acute inflammation typically involves the emigration of monocyte-derived cells out of the inflamed site through nearby lymphatic vessels 3 . This process seems to be impaired in atherosclerosis and has been attributed in part to the loading of cholesterol into macrophages, which shifts these cells to a more sessile phenotype 4 . Studies of transplant-based mouse models of atherosclerosis regression have shown that decreasing plasma non -high-density lipoprotein (non-HDL) cholesterol and / or increasing HDL promotes the emigration of macrophages from lesions to regional and systemic lymph nodes 5 -9 . Macrophage expression of the chemokine receptor CCR7 is essential for decreasing the macrophage content of plaques 8, 9 , which links the CCR7-specific ligands CCL19 and CCL21 to promotion of the egress of these cells from the artery wall. Such studies have indicated that the emigration of macrophages from plaques is actively inhibited during hypercholesterolemia, although the regulatory signals that impair this process remain largely unknown.
A paradigm for inhibitory guidance cues exists in the developing nervous system, where axonal migration relies on the integration of both chemorepulsive and chemoattractive signals to steer the axonal growth cone. One such guidance molecule, netrin-1, a secreted laminin-related molecule, mediates both the chemorepulsion and chemoattraction of axons navigating the spinal cord midline. This context-dependent response to netrin-1 is regulated by differences in receptor expression by the target cell. For example, neurons that express the chemoattractive netrin-1 receptors DCC or neogenin are attracted by a diffusible gradient of netrin-1 secreted at the midline 10 . Conversely, expression of the chemorepulsive netrin-1 receptor UNC5H2 (UNC5b) together with DCC converts attraction by netrin-1 to repulsion by netrin-1, whereas expression of UNC5b alone mediates short-range repulsion 10, 11 . Published studies have identified instructional roles for netrin-1 and its receptors outside the nervous system in organogenesis 12, 13 , angiogenesis 14, 15 and tumorigenesis 16, 17 , which suggests that netrin-1 regulates cell migration in a broader context.
Netrin-1 has been identified as a leukocyte-guidance cue expressed by the endothelium that is downregulated during acute infection with Staphylococcus aureus 18 . Those studies established that netrin-1 inhibits the migration of monocytes, neutrophils and lymphocytes via its receptor, UNC5b. Furthermore, studies of models of hypoxia and reperfusion injury have extended those findings to show that expression of netrin-1 by epithelial cells also attenuates the accumulation of leukocytes 18 -21 . Given its role in inhibiting leukocyte migration, we sought to determine whether netrin-1 contributes to the retention of macrophages in the chronic inflammatory milieu of the atherosclerotic plaque. We found that macrophage foam cells formed in vitro and in vivo and in atherosclerotic lesions expressed netrin-1. In functional studies, we demonstrated that netrin-1 secreted by foam cells regulated the cellular constituents of atheroma differently. Netrin-1 inactivated macrophage migration and supported the chemoattraction of coronary artery SMCs. Thus, expression of netrin-1 in plaques would be predicted to simultaneously prevent the egress of inflammatory cells and induce the recruitment of SMCs into the intima, thereby promoting lesion progression. In support of that hypothesis, we demonstrated that deletion of netrin-1 in myeloid cells resulted in smaller and less-complex atherosclerotic lesions in mice deficient in the receptor for LDL ( Ldlr -/mice) and was associated with the emigration of macrophages from plaques.
RESULTS

Macrophage foam cells express netrin-1
Given its role in attenuating leukocyte migration 18 , we first investigated whether netrin-1 is expressed in atherosclerotic plaques. Immunostaining of serial sections of human coronary artery atherosclerotic plaques showed expression of netrin-1 and UNC5b in lesional cells that expressed the macrophage marker HAM56 ( Supplementary  Fig. 1a,b ). In contrast, we did not detect DCC in these plaques (data not shown). We noted a similar pattern of lesional netrin-1 staining in the Ldlr -/mouse model of atherosclerosis ( Fig. 1a ). In aortic sinus plaques of Ldlr -/mice fed a Western diet for 12 weeks, double staining for netrin-1 and the macrophage marker CD68 showed netrin-1 expression by lesional macrophages. In addition, extracellular netrin-1 staining was apparent in macrophage-rich regions of the plaque, consistent with netrin-1 ' s being a secreted protein that can bind to extracellular matrix components. Analysis of the aortic arch, a second site of predilection toward lesions in mice, showed that Ntn1 mRNA (encoding netrin-1) was more abundant in Ldlr -/mice than in wild-type C57BL / 6 mice and that Ntn1 expression was further upregulated in mice fed a Western diet ( Fig. 1b ). We obtained similar results with the apolipoprotein E -deficient mouse model of atherosclerosis ( Supplementary Fig. 1c ), which indicated that netrin-1 expression by lesional macrophages is a common characteristic of mouse and human atheroma.
To understand the molecular mechanisms that regulate the expression of netrin-1 and UNC5b, we isolated peritoneal macrophages from Ldlr -/mice fed either regular chow or a Western diet; the latter is a commonly used model of the in vivo formation of foam cells. Macrophages from mice fed a Western diet had much higher expression of Ntn1 and Unc5b mRNA, whereas expression of CD68 was unchanged ( Fig. 1c ). We obtained similar results with hypercholesterolemic apolipoprotein E -deficient mice ( Supplementary  Fig. 1d ), which suggested that the accumulation of cellular lipid may upregulate the expression of netrin-1 and UNC5b. To assess that,
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Ldlr npg we treated peritoneal macrophages with native LDL or LDL that had been oxidized (oxLDL), a modification that promotes the loading of cholesterol into macrophages. Consistent with our in vivo data, oxLDL resulted in macrophage expression of Ntn1 and Unc5b mRNA, but LDL did not ( Fig. 1d and Supplementary Fig. 1e ). Immunoblot analysis confirmed that oxLDL-treated macrophages had more cellassociated netrin-1 protein ( Fig. 1e ), which was paralleled by more netrin-1 in cell culture supernatants ( Fig. 1f ). Notably, the induction of Ntn1 mRNA ( Fig. 1g ) and netrin-1 protein ( Supplementary  Fig. 1f ) by oxLDL required CD36, a scavenger receptor that has been linked to the retention of macrophages in atherosclerotic plaques 22 .
Because the binding of oxLDL to CD36 induces activation of the transcription factor NF-κ B 23, 24 and the Ntn1 promoter contains an NF-κ B-binding site 20 , we investigated whether NF-κ B contributes to the upregulation of Ntn1 . Using a human NTN1 promoter -luciferase reporter gene, we found that NTN1 promoter activity was induced by oxLDL and this was diminished by the NF-κ B inhibitor BAY 11-7082 ( Fig. 1h ). Collectively, these data demonstrated that loading of macrophages with cholesterol under physiological conditions, or by oxidized lipids via CD36 in vitro , resulted in higher expression of netrin-1 and its receptor UNC5b.
Netrin-1 blocks the directed migration of macrophages
We next assessed the effect of netrin-1 on macrophage chemotaxis through the use of Transwell Boyden chambers and a real-time detection method. By each method, we found that recombinant netrin-1 potently inhibited chemotaxis of the mouse macrophage cell line RAW264.7 to the chemokine CCL2 (also known as monocyte chemoattractant protein-1 (MCP-1)) but had little effect on macrophage migration in the absence of chemokines ( Fig. 2a,b ). The inhibitory effects of netrin-1 on chemotaxis were dose dependent ( Fig. 2a ); netrin-1 at a dose of 250 ng / ml inhibited CCL2-induced migration by >90 % ( Fig. 2b ). Furthermore, pretreatment of RAW264.7 cells for 1 h with netrin-1 rendered the cells refractory to CCL2 ( Fig. 2c ). Similar to its effects on RAW264.7 macrophages, netrin-1 potently inhibited the chemotaxis of peritoneal macrophages to CCL2 ( Fig. 2d ). This effect was not chemokine specific, as netrin-1 also blocked the migration of RAW264.7 and peritoneal macrophages to the CCR7 ligands CCL19 and CCL21 ( Fig. 2e and Supplementary Fig. 2a g ), chemokines linked to the egress of CD68 + cells from plaques 8, 9 .
To gain insight into the mechanisms by which netrin-1 inhibits macrophage chemotaxis, we measured its effect on the organization of the actin cytoskeleton. Stimulation of peritoneal macrophages ( j ) Immunoblot analysis of phosphorylated (p-) and total FAK in peritoneal macrophages incubated with CCL2 (100 ng / ml) with or without pretreatment with netrin-1 (250 ng / ml); results are presented relative to results at time 0, set as 1. * P < 0.05 and * * P < 0.01 (Student ' s t -test). Data are from one experiment representative of three independent experiments (mean ± s.d. of triplicate samples in a -e , g -j ).
npg with CCL2 or CCL19 induced considerable reorganization of actin, characterized by the appearance of membrane ruffles, lamellipodia and filapodia ( Fig. 2f and Supplementary Fig. 3a ) and rapid cell spreading ( Fig. 2g and Supplementary Fig. 3b ). In contrast, peritoneal macrophages pretreated with netrin-1 before stimulation with CCL2 or CCL19 maintained a rounded morphology ( Fig. 2f and Supplementary Fig. 3a ) and showed no increase in mean cell area ( Fig. 2g and Supplementary Fig. 3b ), consistent with a nonmotile status. Quantification of phalloidin-stained actin filaments by flow cytometry confirmed that netrin-1 blocked the increase in polymerized actin-1 associated with CCL2 stimulation ( Fig. 2h ). As the Rho GTPase Rac1 has a key role in the reorganization of actin in macrophages, we next investigated whether netrin-1 altered Rac1 activation after chemotactic stimulation with glutathione S -transferase beads conjugated to the p21-binding domain of the kinase PAK-1 to detect the activated GTP-bound form of Rac1. Whereas pretreatment of macrophages with netrin-1 resulted in slightly more basal activated Rac1, it inhibited CCL2-induced activation of Rac1 ( Fig. 2i ) and phosphorylation of the adhesion kinase FAK ( Fig. 2j ), which acts together with Rac1 to link the actin cytoskeleton to the extracellular matrix during cell spreading and migration. Collectively, these data indicated that netrin-1 inhibited the directional migration of macrophages by disrupting the Rac1 signaling cascade, reorganization of the actin cytoskeleton and cell polarization.
As both netrin-1 and UNC5b were upregulated in cholesterolloaded macrophages we postulated that netrin-1 secreted by macrophages in atherosclerotic plaques may act in an autocrine or paracrine manner via UNC5b to immobilize these cells in the artery wall. To assess the role of UNC5b in the response to netrin-1, we preincubated macrophages with the extracellular domain of human UNC5B fused to the Fc portion of human immunoglobulin G1 (UNC5b-Fc) or an antibody that binds to the extracellular domain of UNC5b. Both UNC5b-Fc ( Fig. 3a ) and the antibody to Unc5b ( Fig. 3b ) reversed the inhibitory effect of netrin-1 on CCL19-induced migration, but control immunoglobulin G (IgG) did not. In contrast, we found no change with an inhibitor of the A2B adenosine receptor, another netrin-1 receptor linked to the attenuation of neutrophil migration ( Fig. 3c ). Furthermore, consistent with the secretion of netrin-1 by macrophage foam cells, conditioned medium from oxLDL-treated macrophages inhibited the migration of cells to CCL19, but conditioned medium from LDL-treated macrophages did not ( Fig. 3d ), and this was reversed by UNC5b-Fc ( Fig. 3e ). To confirm the proposal that netrin-1 is the active component secreted by oxLDL-treated macrophages, we used peritoneal macrophages isolated from Ntn1 -/bone marrow -chimeric mice, which did not express netrin-1 in response to oxLDL ( Fig. 3f ). Whereas conditioned medium from oxLDL-treated Ntn1 + / + peritoneal macrophages inhibited the migration of naive macrophages toward CCL19 by 80 % , conditioned medium from similarly treated Ntn1 -/macrophages resulted in only 25 % less migration ( Fig. 3f ). Furthermore, conditioned medium from Ntn1 + / + cells incubated with UNC5b-Fc inhibited migration to an extent similar to that achieved by conditioned medium from Ntn1 -/cells ( ~ 25 % ). In contrast, the effects of conditioned medium from Ntn1 -/cells were unchanged by the addition of recombinant UNC5b ( Fig. 3f ). Together these data suggest that netrin-1 secreted by cholesterol-laden macrophages would promote their accumulation in atherosclerotic plaques by inhibiting their emigration from this site of inflammation.
Studies of a mouse model of atherosclerosis regression have demonstrated that macrophages in plaques exit via nearby lymphatics after aggressive lowering of cholesterol concentrations 6 . A similar pathway for macrophage clearance has been reported during resolving peritonitis in which inflammatory macrophages emigrate to the draining lymphatics of the omentum 3, 25 . To assess the effect of netrin-1 on macrophage emigration in vivo , we used the well-characterized thioglycollate-induced peritonitis model in which administration of lipopolysaccharide (LPS) induces the rapid egress of recruited leukocytes from the peritoneum 22 . As reported before 22 , intraperitoneal injection of LPS into control mice given no pretreatment resulted in 75 % fewer leukocytes in the peritoneum ( Fig. 3g ), whereas mice pretreated intraperitoneally with netrin-1 45 min before this inflammatory stimulus showed no significant change in peritoneal leukocytes. Analysis of the macrophage marker F4 / 80 by flow npg cytometry confirmed more retention of macrophages in the peritoneum of mice pretreated with netrin-1 (1.1 × 10 6 ± 0.3 × 10 6 ) than in that of control mice given no pretreatment (0.4 × 10 6 ± 0.1 × 10 6 ). These data demonstrated that netrin-1 inhibited the emigration of macrophages from a site of active inflammation.
Netrin-1 is a chemoattractant for SMCs
During the progression of atherosclerosis, SMCs from the underlying medial layer are recruited to the plaque and participate in promoting plaque growth. To investigate whether netrin-1 expression in plaque affects other cellular components of the atherosclerotic lesion, we measured its effect on migration of human coronary artery SMCs. Unlike its inhibitory effect on macrophages, netrin-1 induced the migration of coronary artery SMCs in a dose-dependent way ( Fig. 4a ).
Furthermore, conditioned medium from oxLDL-treated macrophages induced the migration of these cells but conditioned medium from LDL-treated macrophages did not ( Fig. 4b ). To understand how netrin-1 mediates the chemoattraction of these cells, we measured expression of its known receptors. Although coronary artery SMCs had low expression of DCC and UNC5b, they had abundant expression of the DCC-related receptor neogenin ( Fig. 4c,d ) , as reported before for vascular SMCs 13 . Notably, pretreatment of coronary artery SMCs with antibody to neogenin abrogated the chemoattractant effect of conditioned medium from oxLDL-treated macrophages ( Fig. 4e ), which supported the idea that foam cell -derived netrin-1 induces the migration of SMCs. Immunohistochemical staining of atherosclerotic plaques of Ldlr -/mice showed colocalization of neogenin with smooth muscle actin ( Fig. 4f ) but not with the macrophage Fig. 4a ). Furthermore, neogenin was expressed in medial SMCs and in SMCs that had migrated into the intima, as well as some cells that were not positive for smooth muscle actin ( Fig. 4f ). Together these data indicated that netrin-1 modulated the migration of coronary artery SMCs and macrophages through distinct mechanisms.
Less atherosclerosis with hematopoietic deficiency in netrin-1
On the basis of the data reported above, we postulated that expression of netrin-1 by macrophage foam cells may promote atherosclerotic plaque growth by both blocking macrophage egress and eliciting the recruitment of SMCs to the intima. To test our hypothesis, we used fetal liver cells from Ntn1 -/or Ntn1 + / + pups at embryonic day 14 to reconstitute the bone marrow of lethally irradiated Ldlr -/mice, thereby generating Ldlr -/mice with either Ntn1 -/macrophages ( Ntn1 -/ -→ Ldlr -/ -) or Ntn1 + / + (wild-type) macrophages (WT → Ldlr -/ -). At 4 weeks after transplantation, we challenged the chimeric Ntn1 -/ -→ Ldlr -/and WT → Ldlr -/mice with a Western diet for 12 weeks. Analysis of the expression of Ntn1 and Ldlr in both circulating leukocytes and peritoneal macrophages from the recipient mice confirmed a complete change in genotype to the donor type ( Supplementary Table 1 and Supplementary Fig. 4b ). There was no difference in the serum concentration of total cholesterol or triglyceride or in the cholesterol distribution in very low-density lipoprotein, LDL or HDL in chimeric Ntn1 -/ -→ Ldlr -/or WT → Ldlr -/mice ( Supplementary Table 1 and Supplementary Fig. 4c ). Despite their similar serum cholesterol profiles, Ldlr -/mice lacking expression of Ntn1 in bone marrow -derived cells had much less atherosclerosis ( Fig. 5 ). Analysis of the aorta en face showed that Ntn1 -/ -→ Ldlr -/mice had an atherosclerotic lesion area 55 % smaller than that of WT → Ldlr -/mice ( Fig. 5a ) that was present throughout the aorta ( Supplementary  Fig. 4d ). The aortic arch of Ntn1 -/ -→ Ldlr -/mice had lower expression of mRNA for the macrophage marker CD68 than did that of WT → Ldlr -/mice ( Fig. 5b ) and, correspondingly, had lower expression of Ntn1 ( Fig. 5c ). The aortic arch of Ntn1 -/ -→ Ldlr -/mice also had lower expression of markers for other leukocyte subsets, including CD3 (T cells) and CD11c (dendritic cells; Fig. 5b ). Furthermore, Ntn1 -/ -→ Ldlr -/mice had much smaller atherosclerotic plaques in a second anatomical site, the aortic root, than did WT → Ldlr -/mice ( Fig. 5df ). Quantification of lesion burden by cross-sectional analysis of the aortic root established that this smaller lesion area in Ntn1 -/ -→ Ldlr -/mice was consistently present throughout the 400 μ m of the aortic root ( Fig. 5e ).
Histological characterization of the aortic sinus plaques by the Stary method showed that WT → Ldlr -/mice had more-advanced atherosclerosis, typified by a greater proportion of complex lesions (stages 3 -4), whereas Ntn1 -/ -→ Ldlr -/plaques tended to have undergone less progression (stages 1 -3; Fig. 6a ). Immunohistochemical staining of aortic sinus plaques confirmed that Ntn1 -/ -→ Ldlr -/mice had fewer macrophages (cells positive for MOMA-2; Fig. 6b ) and SMCs ( α -smooth muscle actin; Fig. 6c ) than did WT → Ldlr -/mice. During the progression of atherosclerosis, macrophage persistence contributes to changes in plaque morphology, particularly formation of the necrotic core. This critical feature of dangerous plaques arises from the combination of apoptosis of cholesterol-laden macrophages and defective phagocytic clearance of the apoptotic cells by the surrounding macrophages ( ' efferocytosis ' ). Notably, TUNEL staining (terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling) showed that plaques in Ntn1 -/ -→ Ldlr -/mice contained significantly fewer apoptotic cells than did those in WT → Ldlr -/mice ( Fig. 6d ), and this correlated with a 46 % smaller necrotic area in Ntn1 -/ -→ Ldlr -/plaques ( Fig. 6e ). Together these data suggest that netrin-1 expression by lesional macrophages promotes atherosclerotic plaque growth and complexity by enhancing macrophage retention in the intima.
To determine whether netrin-1 expression in plaques inhibits macrophage emigration, we used a macrophage-tracking technique in which monocytes can be selectively labeled in vivo with fluorescent beads so that their movement into plaques 26 and out of plaques 7 can be monitored. We assessed WT → Ldlr -/and Ntn1 -/ -→ Ldlr -/mice 72 h after the injection of labeled beads, a time point of peak recruitment of labeled cells to atherosclerotic plaque (baseline) 26 , and after 14 d to quantify labeled macrophages that remained in plaques. There was a similar number of bead-labeled macrophages in WT → Ldlr -/plaques npg at baseline and 14 d ( Fig. 6f ), which indicated that macrophages did not emigrate during this time. In contrast, Ntn1 -/ -→ Ldlr -/plaques showed a 40 % decrease in beads after 14 d compared with baseline, which indicated that fewer macrophages were retained in the plaque in the absence of netrin-1. As the beads cannot be degraded, and any labeled macrophages that undergo apoptosis are phagocytosed by surrounding macrophages, which results in transfer of the bead label, the decrease in beads in Ntn1 -/ -→ Ldlr -/mice was indicative of the movement of macrophages out of the plaque. Collectively, our data support the proposal of the retention of macrophages in plaques by netrin-1 and have demonstrated that after the removal of this retention signal, macrophages emigrated from this site of chronic inflammation.
DISCUSSION
It is appreciated that plaques that cause clinical events, so-called ' vulnerable plaques ' , have a high macrophage content 2 . Thus, strategies targeted at diminishing macrophage accumulation and / or directing the emigration of these cells from the plaque offer promise as a complement to standard lipid-lowering therapies. However, so far the signals responsible for mediating macrophage retention in the artery wall have been poorly elucidated. Our data have established that netrin-1, a neuronal guidance molecule with immunomodulatory functions, and its receptor, UNC5b, were expressed by macrophage foam cells of human and mouse atherosclerotic plaques. Notably, recombinant netrin-1 and netrin-1 secreted by in vitro formed foam cells potently blocked the directed migration of macrophages to CCL19, a chemokine linked to the emigration of monocyte-derived cells from plaques in a transplant model of regression 8, 9 . Moreover, netrin-1 also blocked the migration of macrophages to CCL2, which, along with its receptor CCR2, is involved in the trafficking of myeloid cells to the lymph nodes during inflammation 27, 28 . Thus, netrin-1 in plaques may act to immobilize macrophage foam cells and prevent their egress to the lumen or lymphatic system. In support of that hypothesis, we found that the selective deletion of netrin-1 in bone marrow -derived cells resulted in smaller and less-complex atherosclerotic lesions in Ldlr -/mice and was associated with the emigration of macrophages from plaques. Our data have established a causative role for netrin-1 in the persistence of inflammation in atherosclerosis and highlight the importance of such negative regulators of leukocyte migration in chronic inflammation. Several reports have demonstrated that guidance molecules characterized in the developing nervous system can modulate leukocyte migration in inflammatory states 18, 29 -31 . Such studies have shown that members of the netrin, slit, semaphorin and ephrin families of guidance cues can have both chemoattractive and chemorepulsive effects on leukocyte trafficking. Published studies have shown that netrin-1 is expressed on endothelial and epithelial cells, where it seems to function in limiting the transmigration of leukocytes into tissues 18 -20, 32 . For example, endothelial expression of netrin-1 is downregulated in the lungs during acute Staphylococcus aureus -induced inflammation, coincident with the recruitment of neutrophils to the tissues 18 . In contrast, netrin-1 is upregulated on gut epithelial cells during transient ischemia and attenuates the recruitment of neutrophils to protect the host from hypoxia-induced inflammation 20 . Such studies showing that netrin-1 inhibits the migration of circulating leukocytes into tissues and thus is anti-inflammatory in this ability have provided insight into the homeostatic barrier functions of netrin-1. In this context, a published study has reported that intravenous viral delivery of netrin-1 to Ldlr -/mice results in less atherosclerosis 33 , presumably by increasing netrin-1 expression on endothelial cells, although no determination of the cell types expressing netrin-1 were made in that study. Unfortunately, that study was underpowered, and the traditional atherosclerosis measurements of cross-sectional lesion area and en face aortic lesion burden were not assessed, which limits the conclusions that can be drawn from those data. In contrast, our data have indicated that the expression of netrin-1 by macrophage foam cells in plaques was proatherosclerotic and that its inactivation of macrophage emigration from this inflamed site probably inhibited the resolution of inflammation. Thus, as in the nervous system, in which it can have both positive and negative effects on axonal migration, netrin-1 may have multifunctional roles in regulating inflammation depending on the site of its expression.
Although monocytes and most tissue macrophages have low expression of netrin-1, macrophage foam cells in human and mouse atheroma have high expression of netrin-1. The mechanisms of netrin-1 upregulation in this context may be similar to those in hypoxia, during which the hypoxia-induced factor HIF1-α and NF-κ B regulate Ntn1 transcription 19, 20, 34 . Hypoxic stress is intimately linked to atherosclerosis 35 , and these transcription factors are activated in lesional macrophages. The induction of netrin-1 by oxLDL involved activation of NF-κ B via CD36 (refs. 23,24), a scavenger receptor linked to the retention of macrophages in atherosclerosis 22, 36 .
Macrophages that infiltrate the arterial intima are thought to exit via lymphatic vessels or egress into the bloodstream, or undergo apopotosis and efferocytotic clearance 37 -39 . All of those mechanisms seem to be impaired in atherosclerosis, leading to the progressive accumulation of macrophages in plaques. However, studies of mouse models suggest that such processes can be restored with aggressive management of lipids, which provides hope that atherosclerosis regression can be achieved in humans 40 . Genetic manipulations that decrease plasma non-HDL cholesterol and / or increase HDL cholesterol promote the emigration of macrophages from plaques to regional and systemic lymph nodes via a mechanism that involves CCR7, the receptor for CCL19 and CCL21 (refs. 5 -9) . Notably, as netrin-1 blocked the chemotaxis of macrophages toward CCL19 and CCL21, it would be expected to inhibit the normal migratory processes that bring about resolution of inflammation. Consistent with that, deletion of netrin-1 in lesional macrophages in Ldlr -/mice promoted macrophage emigration and resulted in smaller plaques. Although the exact means by which netrin-1 inhibits migration remain to be elucidated, our data have indicated that netrin-1 inhibited Rac-mediated reorganization of the actin cyctoskeleton, preventing cell spreading and the migration of macrophages out of plaques.
In addition to its effects on macrophages, netrin-1 is a potent chemoattractant for coronary artery SMCs, a process dependent on the neogenin receptor. The recruitment of SMCs by netrin-1 represents a second mechanism by which this guidance molecule could promote atherosclerosis. During plaque progression, the internal elastic lamina can become breached and SMCs may migrate into the intima to participate in lesion growth. In plaques of Ntn1 -/ -→ Ldlr -/chimeric mice, we found less accumulation of SMCs, consistent with the idea that loss of netrin-1 both allowed the emigration of macrophages from the plaque and curtailed the recruitment of SMCs into it. Furthermore, Ntn1 -/ -→ Ldlr -/plaques had fewer apoptotic cells and a smaller necrotic area, which indicated that the mechanisms that regulate tissue homeostasis were enhanced in the absence of netrin-1. Together these data underscore the important role that negative guidance cues may have in the persistence of inflammation and indicate that local inhibition of such factors may have therapeutic value for the resolution of inflammation in atherosclerosis and other chronic inflammatory diseases.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Note: Supplementary information is available on the Nature Immunology website.
